14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ITEK
Delisted

Inotek Pharmaceuticals Corporation Fund Price (Quote)

$3.04
+0 (+0%)
At Close: Jan 22, 2018

Range Low Price High Price Comment
30 days $0.0060 $169.56 Monday, 22nd Jan 2018 ITEK stock ended at $3.04. During the day the stock fluctuated 0% from a day low at $3.04 to a day high of $3.04.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Inotek Pharmaceuticals Corporation prices

Date Open High Low Close Volume
Apr 06, 2017 $1.85 $1.90 $1.80 $1.85 696 812
Apr 05, 2017 $1.95 $1.95 $1.85 $1.85 547 194
Apr 04, 2017 $1.90 $2.00 $1.85 $1.95 1 218 988
Apr 03, 2017 $2.00 $2.00 $1.90 $1.90 526 177
Mar 31, 2017 $2.10 $2.10 $1.90 $2.00 1 390 731
Mar 30, 2017 $2.05 $2.20 $2.00 $2.15 2 771 624
Mar 29, 2017 $1.95 $2.00 $1.90 $1.95 1 164 432
Mar 28, 2017 $1.85 $1.90 $1.80 $1.90 718 370
Mar 27, 2017 $1.85 $1.85 $1.80 $1.85 617 036
Mar 24, 2017 $1.75 $1.85 $1.70 $1.80 500 694
Mar 23, 2017 $1.75 $1.75 $1.70 $1.75 260 961
Mar 22, 2017 $1.65 $1.75 $1.60 $1.73 1 929 427
Mar 21, 2017 $1.70 $1.80 $1.65 $1.65 1 087 847
Mar 20, 2017 $1.85 $1.90 $1.70 $1.75 1 264 886
Mar 17, 2017 $1.85 $1.90 $1.85 $1.88 1 052 505
Mar 16, 2017 $1.80 $1.85 $1.75 $1.85 1 719 194
Mar 15, 2017 $1.75 $1.80 $1.70 $1.73 662 393
Mar 14, 2017 $1.85 $1.85 $1.70 $1.75 1 684 950
Mar 13, 2017 $1.75 $1.85 $1.65 $1.78 2 672 776
Mar 10, 2017 $1.60 $1.95 $1.55 $1.70 6 512 360
Mar 09, 2017 $1.60 $1.60 $1.55 $1.55 204 542
Mar 08, 2017 $1.55 $1.60 $1.55 $1.55 693 349
Mar 07, 2017 $1.55 $1.60 $1.55 $1.55 304 343
Mar 06, 2017 $1.60 $1.60 $1.55 $1.55 515 936
Mar 03, 2017 $1.55 $1.60 $1.55 $1.58 521 220
Click to get the best stock tips daily for free!

About Inotek Pharmaceuticals Corporation

Inotek Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for glaucoma and other diseases of the eye in the United States. The company’s lead product candidate includes Trabodenoson, a monotherapy that is in Phase III clinical trials for lowering IOP by restoring the eye’s natural pressure control mechanism. It is also developing Trabodenoson plus La... ITEK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT